{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:49:05Z","timestamp":1776109745381,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR055685"],"award-info":[{"award-number":["R01 AR055685"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012819","name":"Egyptian Cultural and Educational Bureau","doi-asserted-by":"publisher","award":["JS3740"],"award-info":[{"award-number":["JS3740"]}],"id":[{"id":"10.13039\/100012819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inappropriate expression of DUX4, a transcription factor that induces cell death at high levels of expression and impairs myoblast differentiation at low levels of expression, leads to the development of facioscapulohumeral muscular dystrophy (FSHD), however, the pathological mechanisms downstream of DUX4 responsible for muscle loss are poorly defined. We performed a screen of 1972 miR inhibitors for their ability to interfere with DUX4-induced cell death of human immortalized myoblasts. The most potent hit identified by the screen, miR-3202, is known to target the antiapoptotic protein FAIM2. Inhibition of miR-3202 led to the upregulation of FAIM2, and remarkably, expression of DUX4 led to reduced cellular levels of FAIM2. We show that the E3 ubiquitin ligase and DUX4 target gene, TRIM21, is responsible for FAIM2 degradation downstream of DUX4. Human myoblasts overexpressing FAIM2 showed increased resistance to DUX4-induced cell death, whereas in wild-type cells FAIM2 knockdown resulted in increased apoptosis and failure to differentiate into myotubes. The necessity of FAIM2 for myogenic differentiation of WT cells led us to test the effect of FAIM2 overexpression on the impairment of myogenesis by DUX4. Strikingly, FAIM2 overexpression rescued the myogenic differentiation defect caused by low-level expression of DUX4. These data implicate FAIM2 levels, modulated by DUX4 through TRIM21, as an important factor mediating the pathogenicity of DUX4, both in terms of cell viability and myogenic differentiation, and thereby open a new avenue of investigation towards drug targets in FSHD.<\/jats:p>","DOI":"10.1038\/s41419-022-04804-x","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T16:03:31Z","timestamp":1650902611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antiapoptotic Protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis"],"prefix":"10.1038","volume":"13","author":[{"given":"Hossam A. N.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6527-3921","authenticated-orcid":false,"given":"Erik A.","family":"Toso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas E.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-7534","authenticated-orcid":false,"given":"Michael","family":"Kyba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"4804_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.nmd.2013.01.008","volume":"23","author":"JM Statland","year":"2013","unstructured":"Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, et al. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2013;23:306\u201312.","journal-title":"Neuromuscul Disord"},{"key":"4804_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","volume":"83","author":"JCW Deenen","year":"2014","unstructured":"Deenen JCW, Arnts H, Van Der Maarel SM, Padberg GW. Verschuuren JJGM, Bakker E, et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 2014;83:1056\u20139.","journal-title":"Neurology"},{"key":"4804_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0378-1119(99)00267-X","volume":"236","author":"J Gabri\u00ebls","year":"1999","unstructured":"Gabri\u00ebls J, Beckers MC, Ding H, De Vriese A, Plaisance S, Van Der Maarel SM, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999;236:25\u201332.","journal-title":"Gene"},{"key":"4804_CR4","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JCTVA Deutekom","year":"1993","unstructured":"Deutekom JCTVA, Wljmenga C, Tlenhoven EAEVA, Gruter AM, Hewitt JE, Padberg GW, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993;2:2037\u201342.","journal-title":"Hum Mol Genet"},{"key":"4804_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"R Lemmers","year":"2012","unstructured":"Lemmers R, JLF, Tawil R, Petek LM, Balog J, Block GJ, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 2012;44:1370\u20134.","journal-title":"Nat Genet"},{"key":"4804_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML Van Den Boogaard","year":"2016","unstructured":"Van Den Boogaard ML, Lemmers RJLF, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, et al. Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet. 2016;98:1020\u201329.","journal-title":"Am J Hum Genet"},{"key":"4804_CR7","doi-asserted-by":"publisher","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","volume":"94","author":"K Hamanaka","year":"2020","unstructured":"Hamanaka K, \u0160ikrov\u00e1 D, Mitsuhashi S, Masuda H, Sekiguchi Y, Sugiyama A, et al. Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology 2020;94:e2441\u20137.","journal-title":"Neurology"},{"key":"4804_CR8","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/emboj.2008.201","volume":"27","author":"D Bosnakovski","year":"2008","unstructured":"Bosnakovski D, Xu Z, Ji Gang E, Galindo CL, Liu M, Simsek T, et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 2008;27:2766\u201379.","journal-title":"EMBO J"},{"key":"4804_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","volume":"22","author":"LN Geng","year":"2012","unstructured":"Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell. 2012;22:38\u201351.","journal-title":"Dev Cell"},{"key":"4804_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","volume":"17","author":"V Kowaljow","year":"2007","unstructured":"Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Matt\u00e9otti C, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord. 2007;17:611\u201323.","journal-title":"Neuromuscul Disord"},{"key":"4804_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35150-8","volume":"8","author":"D Bosnakovski","year":"2018","unstructured":"Bosnakovski D, Gearhart MD, Toso EA, Ener ET, Choi SH, Kyba M. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression. Sci Rep. 2018;8:16957.","journal-title":"Sci Rep"},{"key":"4804_CR12","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1242\/jcs.180372","volume":"129","author":"P Knopp","year":"2016","unstructured":"Knopp P, Krom YD, Banerji CRS, Panamarova M, Moyle LA, den Hamer B, et al. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis. J Cell Sci. 2016;129:3816\u201331.","journal-title":"J Cell Sci"},{"key":"4804_CR13","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1093\/nar\/gkw141","volume":"44","author":"SH Choi","year":"2016","unstructured":"Choi SH, Gearhart MD, Cui Z, Bosnakovski D, Kim M, Schennum N, et al. DUX4 recruits p300\/CBP through its C-terminus and induces global H3K27 acetylation changes. Nucleic Acids Res. 2016;44:5161\u201373.","journal-title":"Nucleic Acids Res"},{"key":"4804_CR14","doi-asserted-by":"publisher","first-page":"eaaw7781","DOI":"10.1126\/sciadv.aaw7781","volume":"5","author":"D Bosnakovski","year":"2019","unstructured":"Bosnakovski D, da Silva MT, Sunny ST, Ener ET, Toso EA, Yuan C, et al. A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death. Sci Adv. 2019;5:eaaw7781.","journal-title":"Sci Adv"},{"key":"4804_CR15","doi-asserted-by":"publisher","first-page":"e1006658","DOI":"10.1371\/journal.pgen.1006658","volume":"13","author":"SC Shadle","year":"2017","unstructured":"Shadle SC, Zhong JW, Campbell AE, Conerly ML, Jagannathan S, Wong CJ, et al. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet. 2017;13:e1006658.","journal-title":"PLoS Genet"},{"key":"4804_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ana.22275","volume":"69","author":"LM Wallace","year":"2011","unstructured":"Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2011;69:540\u201352.","journal-title":"Ann Neurol"},{"key":"4804_CR17","first-page":"1211","volume":"10","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski D, Gearhart MD, Toso EA, Recht OO, Cucak A, Jain AK, et al. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy. DMM Dis Model Mech. 2017;10:1211\u201316.","journal-title":"DMM Dis Model Mech"},{"key":"4804_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/acn3.158","volume":"2","author":"S Homma","year":"2015","unstructured":"Homma S, Beermann ML, Boyce FM, Miller JB. Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation. Ann Clin Transl Neurol. 2015;2:151\u201366.","journal-title":"Ann Clin Transl Neurol"},{"key":"4804_CR19","doi-asserted-by":"publisher","first-page":"eaaw7099","DOI":"10.1126\/sciadv.aaw7099","volume":"5","author":"AM DeSimone","year":"2019","unstructured":"DeSimone AM, Leszyk J, Wagner K, Emerson CP. Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy. Sci Adv. 2019;5:eaaw7099.","journal-title":"Sci Adv"},{"key":"4804_CR20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.25143","volume":"5127","author":"H Nakano","year":"2010","unstructured":"Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XLin colorectal cancer cells. Int J Cancer. 2010;5127:1072\u201380.","journal-title":"Int J Cancer"},{"key":"4804_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bone.2013.05.020","volume":"56","author":"F Ji","year":"2013","unstructured":"Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, et al. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 2013;56:220\u20136.","journal-title":"Bone"},{"key":"4804_CR22","doi-asserted-by":"publisher","first-page":"e91546","DOI":"10.1371\/journal.pone.0091546","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Schiff D, Park D, Abounader R. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One. 2014;9:e91546.","journal-title":"PLoS One"},{"key":"4804_CR23","doi-asserted-by":"publisher","first-page":"29897","DOI":"10.1074\/jbc.M804612200","volume":"283","author":"TE Miller","year":"2008","unstructured":"Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, et al. MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem. 2008;283:29897\u2013903.","journal-title":"J Biol Chem"},{"key":"4804_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.molonc.2012.10.011","volume":"7","author":"P Wang","year":"2013","unstructured":"Wang P, Zhuang L, Zhang J, Fan J, Luo J, Chen H, et al. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol Oncol. 2013;7:334\u201345.","journal-title":"Mol Oncol"},{"key":"4804_CR25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3811","author":"AJ Favreau","year":"2013","unstructured":"Favreau AJ, Shaffiey F, Cross E, Sathyanarayana P. Mir-590 is a novel STAT5 regulated oncogenic miRNA and targets FasL in acute myeloid leukemia. Blood 2013. https:\/\/doi.org\/10.1182\/blood.V122.21.3811","journal-title":"Blood"},{"key":"4804_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/0008-5472.CAN-11-1460","volume":"72","author":"G Huang","year":"2012","unstructured":"Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating fas expression. Cancer Res. 2012;72:908\u201316.","journal-title":"Cancer Res"},{"key":"4804_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-4-4.","author":"D Bosnakovski","year":"2014","unstructured":"Bosnakovski D, Choi SH, Strasser JM, Toso EA, Walters MA, Kyba M. High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity. Skelet Muscle. 2014. https:\/\/doi.org\/10.1186\/2044-5040-4-4.","journal-title":"Skelet Muscle"},{"key":"4804_CR28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1177\/1087057116651868","volume":"21","author":"SH Choi","year":"2016","unstructured":"Choi SH, Bosnakovski D, Strasser JM, Toso EA, Walters MA, Kyba M. Transcriptional inhibitors identified in a 160,000-compound small-molecule DUX4 viability screen. J Biomol Screen. 2016;21:680\u20138.","journal-title":"J Biomol Screen"},{"key":"4804_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27430-1","volume":"12","author":"NY Saad","year":"2021","unstructured":"Saad NY, Al-Kharsan M, Garwick-Coppens SE, Chermahini GA, Harper MA, Palo A, et al. Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for facioscapulohumeral muscular dystrophy. Nat Commun. 2021;12:7128.","journal-title":"Nat Commun"},{"key":"4804_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2015.12.013","volume":"410","author":"M Horak","year":"2016","unstructured":"Horak M, Novak J, Bienertova-Vasku J. Muscle-specific microRNAs in skeletal muscle development. Dev Biol 2016;410:1\u201313.","journal-title":"Dev Biol"},{"key":"4804_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep21620.","author":"W Lu","year":"2016","unstructured":"Lu W, Huang SY, Su L, Zhao BX, Miao JY. Long noncoding RNA LOC100129973 suppresses apoptosis by targeting MIR-4707-5p and MIR-4767 in vascular endothelial cells. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep21620.","journal-title":"Sci Rep"},{"key":"4804_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.12659\/MSM.899443","volume":"23","author":"X Huang","year":"2017","unstructured":"Huang X, Xie H, Xue G, Ye M, Zhang L. MiR-3202\u2014promoted H5V cell apoptosis by directly targeting fas apoptotic inhibitory molecule 2 (FAIM2) in high glucose condition. Med Sci Monit. 2017;23:975\u201383.","journal-title":"Med Sci Monit"},{"key":"4804_CR33","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181523.","author":"Q Guo","year":"2019","unstructured":"Guo Q, Zheng M, Xu Y, Wang N, Zhao W. MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen \u03b1-1(X) chain gene. Biosci Rep. 2019. https:\/\/doi.org\/10.1042\/BSR20181523.","journal-title":"Biosci Rep"},{"key":"4804_CR34","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1002\/jcb.27323","volume":"120","author":"L Wang","year":"2019","unstructured":"Wang L, Sun J, Cao H. MicroRNA-384 regulates cell proliferation and apoptosis through directly targeting WISP1 in laryngeal cancer. J Cell Biochem. 2019;120:3018\u201326.","journal-title":"J Cell Biochem"},{"key":"4804_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yexcr.2017.11.038","volume":"362","author":"W Shen","year":"2018","unstructured":"Shen W, Liu J, Fan M, Wang S, Zhang Y, Wen L, et al. MiR-3202 protects smokers from chronic obstructive pulmonary disease through inhibiting FAIM2: An in vivo and in vitro study. Exp Cell Res. 2018;362:370\u201377.","journal-title":"Exp Cell Res"},{"key":"4804_CR36","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1073\/pnas.96.22.12667","volume":"96","author":"NV Somia","year":"1999","unstructured":"Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma IM. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci USA. 1999;96:12667\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4804_CR37","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gad.10.10.1173","volume":"10","author":"LA Megeney","year":"1996","unstructured":"Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 1996;10:1173\u201383.","journal-title":"Genes Dev"},{"key":"4804_CR38","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3892\/ijo.2015.3169","volume":"47","author":"J M\u00fcller","year":"2015","unstructured":"M\u00fcller J, Maurer V, Reimers K, Vogt PM, Bucan V. TRIM21, a negative modulator of LFG in breast carcinoma MDA-MB-231 cells in vitro. Int J Oncol. 2015;47:1634\u201346.","journal-title":"Int J Oncol"},{"key":"4804_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Disco. 2017;16:203\u201322.","journal-title":"Nat Rev Drug Disco"},{"key":"4804_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tig.2008.01.007","volume":"24","author":"E van Rooij","year":"2008","unstructured":"van Rooij E, Liu N, Olson EN. MicroRNAs flex their muscles. Trends Genet. 2008;24:159\u201366.","journal-title":"Trends Genet"},{"key":"4804_CR41","first-page":"1","volume":"28","author":"NY Saad","year":"2020","unstructured":"Saad NY, Chermahini GA, Al-Kharsan M, Garwick-Coppens SHS. Investigation of the natural miRNA miR-675 as a prospective RNAi-based gene therapy product for facioscapulohumeral muscular dystrophy (FSHD). Mol Ther. 2020;28:1\u2013592.","journal-title":"Mol Ther"},{"key":"4804_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1523\/JNEUROSCI.2188-10.2011","volume":"31","author":"A Reich","year":"2011","unstructured":"Reich A, Spering C, Gertz K, Harms C, Gerhardt E, Kronenberg G, et al. Fas\/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J Neurosci. 2011;31:225\u201333.","journal-title":"J Neurosci"},{"key":"4804_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0000000000000020","volume":"73","author":"SC Tauber","year":"2014","unstructured":"Tauber SC, Harms K, Falkenburger B, Weis J, Sellhaus B, Nau R, et al. Modulation of hippocampal neuroplasticity by Fas\/CD95 regulatory protein 2 (Faim2) in the course of bacterial meningitis. J Neuropathol Exp Neurol. 2014;73:2\u201313.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4804_CR44","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jnc.13847","volume":"139","author":"D Komnig","year":"2016","unstructured":"Komnig D, Schulz JB, Reich A, Falkenburger BH. Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease. J Neurochem. 2016;139:848\u201357.","journal-title":"J Neurochem"},{"key":"4804_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-13-5.","author":"D Corella","year":"2014","unstructured":"Corella D, Sorl\u00ed JV, Gonz\u00e1lez JI, Ortega C, Fit\u00f3 M, Bull\u00f3 M, et al. Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial. Cardiovasc Diabetol. 2014. https:\/\/doi.org\/10.1186\/1475-2840-13-5.","journal-title":"Cardiovasc Diabetol"},{"key":"4804_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/hmg\/ddv472","volume":"25","author":"JF Felix","year":"2016","unstructured":"Felix JF, Bradfield JP, Monnereau C, Van Der Valk RJP, Stergiakouli E, Chesi A, et al. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index. Hum Mol Genet. 2016;25:389\u2013403.","journal-title":"Hum Mol Genet"},{"key":"4804_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep34022","volume":"6","author":"HC Kang","year":"2016","unstructured":"Kang HC, Kim JI, Chang HK, Woodard G, Choi YS, Ku JL, et al. FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid. Sci Rep. 2016;6:34022.","journal-title":"Sci Rep"},{"key":"4804_CR48","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3892\/or.2016.5105","volume":"36","author":"K She","year":"2016","unstructured":"She K, Huang J, Zhou H, Huang T, Chen G, He J. LncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. Oncol Rep. 2016;36:2673\u201380.","journal-title":"Oncol Rep"},{"key":"4804_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.biopha.2015.12.022","volume":"77","author":"D Radin","year":"2016","unstructured":"Radin D, Lippa A, Patel P, Leonardi D. Lifeguard inhibition of Fas-mediated apoptosis: a possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells. Biomed Pharmacother. 2016;77:161\u20136.","journal-title":"Biomed Pharmacother"},{"key":"4804_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.356","volume":"5","author":"L Planells-Ferrer","year":"2014","unstructured":"Planells-Ferrer L, Urresti J, Soriano A, Reix S, Murphy DM, Ferreres JC, et al. MYCN repression of Lifeguard\/FAIM2 enhances neuroblastoma aggressiveness. Cell Death Dis. 2014;5:e1401.","journal-title":"Cell Death Dis"},{"key":"4804_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.109.","author":"M Pawar","year":"2017","unstructured":"Pawar M, Busov B, Chandrasekhar A, Yao J, Zacks DN, Besirli CG. FAS apoptotic inhibitory molecule 2 is a stress-induced intrinsic neuroprotective factor in the retina. Cell Death Differ. 2017. https:\/\/doi.org\/10.1038\/cdd.2017.109.","journal-title":"Cell Death Differ"},{"key":"4804_CR52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1074\/jbc.M115.677682","volume":"291","author":"J Urresti","year":"2016","unstructured":"Urresti J, Ruiz-Meana M, Coccia E, Ar\u00e9valo JC, Castellano J, Fern\u00e1ndez-Sanz C, et al. Lifeguard inhibits fas ligandmediated endoplasmic reticulum-calcium release mandatory for apoptosis in type II apoptotic cells. J Biol Chem. 2016;291:1221\u201334.","journal-title":"J Biol Chem"},{"key":"4804_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014074107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA. 2010. https:\/\/doi.org\/10.1073\/pnas.1014074107","journal-title":"Proc Natl Acad Sci USA"},{"key":"4804_CR54","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41596-018-0028-3","volume":"13","author":"D Clift","year":"2018","unstructured":"Clift D, So C, McEwan WA, James LC, Schuh M. Acute and rapid degradation of endogenous proteins by Trim-Away. Nat Protoc. 2018;13:2149\u201375.","journal-title":"Nat Protoc"},{"key":"4804_CR55","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.molcel.2016.02.007","volume":"61","author":"JA Pan","year":"2016","unstructured":"Pan JA, Sun Y, Jiang YP, Bott AJ, Jaber N, Dou Z, et al. TRIM21 ubiquitylates SQSTM1\/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell. 2016;61:720\u201333.","journal-title":"Mol Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04804-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:16:44Z","timestamp":1700493404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["4804"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04804-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work does not involve animal or human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"405"}}